US2022196646A1PendingUtilityA1
Method for manufacturing protein bioelectronic devices
Est. expiryDec 18, 2040(~14.4 yrs left)· nominal 20-yr term from priority
C12Q 1/005C12Q 1/48G01N 2035/00168G01N 33/5438C12Q 1/6869G01N 2333/9125G01N 27/04
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides devices, systems, and methods related to protein bioelectronics. In particular, the present disclosure provides devices, systems, and methods for forming electrical contacts to a protein with high yield, which facilitates the manufacture of analytical devices to detect and measure the electrical characteristics corresponding to protein function.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of manufacturing a device for direct measurement of protein activity, the method comprising:
combining a first and second electrode with a protein-of-interest to form an electrical connection between the electrodes, wherein the first and second electrodes comprise surfaces chemically modified with a linker molecule, and wherein the protein-of-interest comprises at least one non-canonical amino acid; wherein applying a voltage bias to the electrodes produces current flow through the protein-of-interest.
2 . The method of claim 1 , wherein fluctuations in activity of the protein-of-interest correspond to fluctuations in current.
3 . The method of claim 1 , wherein the surfaces of the first and second electrodes are chemically modified with at least one thiolated biotin linker molecule.
4 . The method of claim 1 , wherein the at least one non-canonical amino acid comprises biotin or a derivative thereof.
5 . The method of claim 4 , wherein the at least one non-canonical amino acid is biocytin or a derivative thereof.
6 . The method of claim 4 , wherein the protein-of-interest comprises two biocytin non-canonical amino acids or derivatives thereof.
7 . The method of claim 1 , wherein the protein-of-interest comprises an Avitag sequence or a derivative thereof.
8 . The method of claim 1 , wherein the protein-of-interest does not comprise an Avitag sequence or a derivative thereof.
9 . The method of claim 1 , wherein the method further comprises adding a second linker molecule to form the electrical connection.
10 . The method of claim 9 , wherein the second linker molecule comprises a streptavidin molecule.
11 . The method of claim 10 , wherein the streptavidin molecule comprises at least two biotin binding sites.
12 . The method of claim 1 , wherein the protein-of-interest comprises the least one non-canonical amino acid at two distinct locations.
13 . The method of claim 12 , wherein the distinct locations comprise at least one of: (i) non-adjacent locations; (ii) locations that do not undergo substantial movement during protein activity; (iii) locations that are on an accessible surface of the protein-of-interest; and/or (iv) locations that are separated by at least 5 nm.
14 . The method of claim 1 , wherein the protein-of-interest is selected from the group consisting of a polymerase, a nuclease, a proteasome, a glycopeptidase, a glycosidase, a kinase and an endonuclease.
15 . The method of claim 1 , wherein the protein-of-interest is a polymerase.
16 . The method of claim 15 , wherein exonuclease activity of the polymerase is disabled.
17 . A device for direct measurement of protein activity, the device comprising:
a first electrode and a second electrode, wherein the first and second electrodes comprise surfaces chemically modified with at least one thiolated biotin linker molecule; and a protein-of-interest that forms an electrical connection between the first and second electrodes comprising at least one non-canonical amino acid, wherein the at least one non-canonical amino acid comprises biotin or a derivative thereof; wherein applying a voltage bias to the electrodes produces current flow through the protein-of-interest.
18 . The device of claim 17 , wherein fluctuations in activity of the protein-of-interest correspond to fluctuations in current.
19 . The device of claim 17 , wherein the at least one non-canonical amino acid is biocytin or a derivative thereof.
20 . The device of claim 17 , wherein the protein-of-interest comprises two biocytin non-canonical amino acids or derivatives thereof.
21 . The device of claim 17 , wherein the protein-of-interest comprises an Avitag sequence or a derivative thereof.
22 . The device of claim 17 , wherein the protein-of-interest does not comprise an Avitag sequence or a derivative thereof.
23 . The device of claim 17 , wherein the device further comprises a second linker molecule comprising a streptavidin molecule.
24 . The device of claim 17 , wherein the protein-of-interest comprises the least one non-canonical amino acid at two distinct locations.
25 . The device of claim 24 , wherein the distinct locations comprise at least one of: (i) non-adjacent locations; (ii) locations that do not undergo substantial movement during protein activity; (iii) locations that are on an accessible surface of the protein-of-interest; and/or (iv) locations that are separated by at least 5 nm.
26 . The device of claim 17 , wherein the protein-of-interest is selected from the group consisting of a polymerase, a nuclease, a proteasome, a glycopeptidase, a glycosidase, a kinase and an endonuclease.
27 . The device of claim 17 , wherein the protein-of-interest is a polymerase.
28 . The device of claim 27 , wherein exonuclease activity of the polymerase is disabled.
29 . A system for direct electrical measurement of protein activity, the system comprising:
the device of claim 17 ; a means for introducing a chemical entity that is capable of interacting with the protein-of-interest; a means for applying a voltage bias between the first and second electrodes that is 100 mV or less; and a means for monitoring fluctuations that occur as the chemical entity interacts with the protein-of-interest.Join the waitlist — get patent alerts
Track US2022196646A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.